SecBot SecBot

PFSA

Profusa, Inc.
Nasdaq· Surgical & Medical Instruments & Apparatus· Inc. DE· CIK 0001859807 Healthcare & Medical Devices
$0.7725 −0.07 (−7.93%)
Oct 26 4:00 PM ET · prev $0.8390
Market cap
$617.8K
Nano cap
Next earnings
Nov 17
in 22 days
1 year
−100.0%
from $2,220.00 · Oct 27
30 days
−54.3%
from $1.69
52-week range
$0.7725–2,220.00
at the low
Avg volume 20D
3.34M
Oct 22 spike 45.02M
Short interest
160.7K
≈26.5% of shares · +409.3%
Days to cover
1.0
at average volume
Insider net
+$7.0T
3 buyers · 1 seller · 12 mo
New fund stakes
0
Q2 2026 13F · 0 exits
Reddit crowd
50°
Neutral · 1 mention this week
Filing reports
15
analyzed by SecBot
SecBot read BEARISH 12 reports · 90 days
Balance 5 bearish · 2 bullish · 5 neutral oldest → newest, height = score
Avg score ·High conf. 9/12 ·Next Earnings date, Nov 17, 2026
Strongest BEARISH Profusa dismissed its auditor CBIZ CPAs P.C. and engaged WithumSmith+Brown, PC as its new independent…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersBULLISH

    3 insiders bought $7.0T. 1 insider sold $153.2K.

  • InstitutionsMIXED

    Q2 2026: 1 added (0 new), 1 trimmed or exited.

  • Short sellersBUILDING

    Short interest +409.3% to 160.7K shares. 1.0 days to cover, ≈26.5% of shares.

  • TrendDOWNTREND

    75% below its 50-day average. New closing low $0.7725 on Oct 26.

  • SocialQUIET

    Crowd 50° (neutral) this week from 1 mention: 0 bullish, 0 bearish. No setup call.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
GEODE CAPITAL MANAGEMENT, LLCTRIM16,417$1.9K
FMR LLCDOUBLED500$58.00

Quarterly 13F filings are due 45 days after each quarter ends.

Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 15, 2026 Press
Profusa received ISO 13485:2016 certification from GMED, a key step toward EU MDR certification and CE marking for its…
Impact 4/10
Oct 15, 2026 Announcement
Profusa Receives ISO 13485:2016 Certificate from GMED
Providing a Foundational Quality Management System (QMS) for Commercialization Certificate issued by
Oct 15, 2026 SEC
Profusa issued a $769,231 senior secured convertible promissory note to Ascent Partners Fund LLC for $700,000 in cash…
8-K — Impact 6/10
Oct 9, 2026 SEC
Profusa dismissed its auditor CBIZ CPAs P.C. and engaged WithumSmith+Brown, PC as its new independent registered…
8-K — Impact 7/10
Oct 5, 2026 SEC
Profusa amended two senior secured convertible notes held by Ascent Partners Fund LLC, raising the conversion price…
8-K — Impact 5/10
Sep 24, 2026 Press
Profusa received a positive decision from GMED regarding ISO 13485 certification of its quality management system, a…
Impact 4/10
Aug 21, 2026 Insider
STOVER JACK E disposed of 301,991 shares
Chief Executive Officer
Aug 21, 2026 Insider
STOVER JACK E acquired 32,018 shares
Chief Executive Officer
Reddit
Crowd this week 50° Neutral 0 bullish · 0 bearish
Mentions, 7 days 1 1 in posts · 0 in comments
Recent posts
r/smallstreetbets Neutral 4d ago
⚡MORNING WATCHLIST⚡
3 upvotes · 2 comments
All social signals and their track records

Insider ledger

Form 4
$7.0T
bought · 3 insiders
$153.2K
sold · 1 insider
DateInsiderTypeValue
Aug 21, 2026
STOVER JACK E
Chief Executive Officer
OTHER301,991 sh
Aug 21, 2026
STOVER JACK E
Chief Executive Officer
OTHER32,018 sh
Aug 21, 2026
Knechtel Fred S.
Chief Financial Officer
OTHER54,323 sh
Aug 21, 2026
Knechtel Fred S.
Chief Financial Officer
OTHER301,991 sh
Aug 17, 2026
HRT FINANCIAL LP
10%+ Owner
SELL$109.3K
Aug 14, 2026
HRT FINANCIAL LP
10%+ Owner
SELL$2.9K
Aug 13, 2026
HRT FINANCIAL LP
10%+ Owner
SELL$37.7K
Aug 12, 2026
HRT FINANCIAL LP
10%+ Owner
BUY$5.4K

Earnings setup

Estimates
Nov 17
reports in 22 days
PeriodEPS est.Range30D rev.Revenue
Current Q———$0.00
Next Q———$0.00
Current FY———$0.00
Next FY———$0.00

Short side

FINRA· Sep 30, 2026
160,653
shares short
+409.3%
vs prior settlement
1.0
days to cover
≈26.5%
of shares outstanding
Trading halts
Aug 28, 2026Volatility PauseResumed
Aug 24, 2026Volatility PauseResumed
Aug 24, 2026Volatility PauseResumed
Aug 20, 2026Volatility PauseResumed
Aug 20, 2026Volatility PauseResumed
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Nov 17, 2026
Earnings date
PFSA Q3 2026 Earnings Scheduled — 2026-11-17
Recent
Oct 15, 2026
Announcement
Profusa Receives ISO 13485:2016 Certificate from GMED
Providing a Foundational Quality Management System (QMS) for Commercialization Certificate issued by GMED, an EU MDR notified body,...
Sep 24, 2026
Announcement
Profusa Announces Significant Progress Towards Lumee® Oxygen Platform CE Mark with ISO 13485 Certification Expected in Early October
BERKELEY, CA, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (Nasdaq: PFSA), a digital health company pioneering next-generation biosensor…
Sep 24, 2026
Reg SHO list
Reg SHO Threshold: PFSA exited the threshold list
PROFUSA INC COM PAR $0.0001 NE | On list since 2026-08-24
Sep 15, 2026
Press release
Profusa, Inc. Receives Nasdaq Compliance Determination
Berkeley, CA, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (Nasdaq: PFSA) (the “Company”) announced today that on September 9, 2026, the Company…
Sep 9, 2026
Listing
Listing Status: PFSA — Normal (was Deficient)
Profusa, Inc. - Common Stock | Nasdaq Financial Status Indicator D → N

SecBot reports

15 filings · 4 press releases · 3 bullish · 6 bearish · 1 mixed · 5 neutral
All PFSA filing & press-release reports (19)